Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
AstraZeneca
Takeda
HistoSonics, Inc.
Medtronic - MITG
SWOG Cancer Research Network
Pfizer
Bristol-Myers Squibb
Institut Bergonié
Merck Sharp & Dohme LLC
Elevation Oncology